CareLit · DOI-Nachweis · Das Gesundheitswesen
Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with AML
DOI 10.1055/s-0035-1563011
Bibliografische Angaben
Nachweis in CareLit
Autor:innenHörster, L.; Wasem, J.; Ganser, A.; Stadler, M.; Schlenk, R.; Port, M.; Gabriel, M.; Schildmann, J.; Rochau, U.; Sroczynski, G.
ZeitschriftDas Gesundheitswesen
Ausgabe8/09/2015
Jahrgang / SeitenJg. 77 · S. 1 bis 1
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction/Background: Acute myeloid leukemia is a clonal disease of hematopoietic progenitor cells and can lead to death within a few weeks without treatment. In recent times increasingly cytogenetic and even more importantly molecular genetic data are used in prognostication of clinical outcome including response to intensive chemotherapy and survival. Nowadays the genetic profile permits a detailed risk-classif…
Zitieren
Zitierempfehlung
Hörster, L.; Wasem, J.; Ganser, A.; Stadler, M.; Schlenk, R.; Port, M.; Gabriel, M.; Schildmann, J.; Rochau, U.; Sroczynski, G (2015) Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with AML. Das Gesundheitswesen, 77 (8/09), 1 bis 1. https://doi.org/10.1055/s-0035-1563011
Mit CareLit weiterarbeiten